Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Q3 2010 Results

26th Oct 2010 07:00

RNS Number : 9814U
ARM Holdings PLC
26 October 2010
 



 

ARM HOLDINGS PLC REPORTS RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2010

 

 A conference call discussing these results will be webcast today at 8:30 BST at www.arm.com/ir

 

CAMBRIDGE, UK, 26 October 2010-ARM Holdings plc announces its unaudited financial results for the third quarter and nine months ended 30 September 2010. Continuing adoption of ARM technology by leading semiconductor companies in a broad range of end-markets is delivering strong revenues, profits and cash.

 

 

Q3 Financial Summary

Normalised*

IFRS

Q3 2010

Q3 2009

% Change

 

Q3 2010

Q3 2009

Revenue ($m)

158.1

123.0

29%

158.1

123.0

Revenue (£m)

100.4

75.2

34%

 

100.4

75.2

Operating margin

37.7%

31.7%

 

 

18.6%

9.6%

Profit before tax (£m)

38.8

24.3

60%

 

19.6

7.7

Earnings per share (pence)

2.08

1.34

55%

 

1.09

0.53

Net cash generation (£m)**

65.0

28.3

 

 

 

 

Effective revenue fx rate ($/£)

1.58

1.64

 

 

 

 

 

YTD Financial Summary

 

Normalised*

IFRS

YTD 2010

YTD 2009

% Change

 

YTD 2010

YTD 2009

Revenue ($m)

451.7

349.4

29%

451.7

349.4

Revenue (£m)

292.6

219.8

33%

 

292.6

219.8

Operating margin

40.1%

28.8%

 

 

24.8%

11.8%

Profit before tax (£m)

119.9

64.5

86%

 

75.1

27.1

Earnings per share (pence)

6.45

3.66

76%

 

4.17

1.79

Net cash generation (£m)**

139.2

55.4

 

 

 

 

Effective revenue fx rate ($/£)

1.54

1.59

 

 

 

 

 

Progress on key growth drivers

·; Growth in mobile applications - ARM opportunity increasing with mobile phones, smart phones and now mobile computers growing strongly

o 900 million ARM®-processor based chips were shipped in mobile devices

o 4 processor licenses signed for mobile phone and computing applications

·; Growth beyond mobile - Increased share in target markets such as consumer electronics and embedded products

o 600 million ARM-processor based chips shipped in everything from toys to televisions, cameras to cars

o 18 processor licenses signed for a broad range of applications including advanced processors for use in new markets such as network infrastructure and sensors

·; Growth in new technology outsourcing

o 3 licenses for royalty-bearing platforms of physical IP at advanced nodes and mature nodes including TSMC licensing physical IP for 28nm and 20nm, as previously reported

o 2 licenses for Mali™, ARM's advanced graphics processor

 

Warren East, Chief Executive Officer, said:

"Q3 was a good quarter for ARM. Not only are we benefiting from growth in applications where we are the established market leader, including in smartphones and mobile computers, but we are gaining share in markets like digital TV and microcontrollers. Our partners are also starting to develop chips in new markets for ARM, such as servers and laptops, creating longer-term opportunities. In addition, both physical IP and Mali graphics performed well with important license wins and increasing royalty revenues.

 

Given the broadening growth opportunities that are available to us, we have accelerated investment in R&D in the first nine months of the year whilst also increasing both profits and cash generation."

 

Outlook

We enter the final quarter of 2010 with positive momentum and we expect sequential group dollar revenue growth in the fourth quarter.

 

Looking further ahead, despite an uncertain macro-economic environment, ARM remains well positioned for growth with leading semiconductor companies increasingly adopting ARM technology for a broadening range of end-markets.

 

 

Q3 2010 - Revenue Analysis

 

Revenue ($m)***

 

Revenue (£m)

 

Q3 2010

Q3 2009

% Change

 

Q3 2010

Q3 2009

% Change

PD

 

 

 

 

 

 

 

Licensing

42.2

30.9

37%

 

26.6

18.5

43%

Royalties

70.4

53.1

33%

 

44.8

32.3

39%

Total PD

112.6

84.0

34%

 

71.4

50.8

40%

PIPD

 

 

 

 

 

 

 

Licensing

10.5

8.8

20%

 

6.7

5.6

20%

Royalties1

11.3

9.2

22%

 

7.2

5.7

27%

Total PIPD

21.8

18.0

21%

 

13.9

11.3

23%

Development Systems

15.6

14.0

11%

 

10.0

8.7

16%

Services

8.1

7.0

15%

 

5.1

4.4

15%

Total Revenue

158.1

123.0

29%

 

100.4

75.2

34%

1 Includes catch-up PIPD royalties in Q3 2010 of $0.6m (£0.4m) and in Q3 2009 of $nil.

 

 

YTD 2010 - Revenue Analysis

 

Revenue ($m)***

 

Revenue (£m)

 

YTD 2010

YTD 2009

% Change

 

YTD 2010

YTD 2009

% Change

PD

 

 

 

 

 

 

 

Licensing

113.0

92.4

22%

 

72.0

55.0

31%

Royalties1

209.6

144.7

45%

 

137.3

94.1

46%

Total PD

322.6

237.1

36%

 

209.3

149.1

40%

PIPD

 

 

 

 

 

 

 

Licensing

29.8

26.7

11%

 

19.1

16.2

18%

Royalties2

31.8

25.1

27%

 

20.7

16.1

28%

Total PIPD

61.6

51.8

19%

 

39.8

32.3

23%

Development Systems

43.8

38.8

13%

 

28.6

25.1

14%

Services

23.7

21.7

9%

 

14.9

13.3

12%

Total Revenue

451.7

349.4

29%

 

292.6

219.8

33%

1 Includes catch-up PD royalties in YTD 2010 of $9.0m (£6.2m).

2 Includes catch-up PIPD royalties in YTD 2010 of $1.4m (£0.9m) and in YTD 2009 of $4.2m (£2.6m).

 

*

Normalised non-GAAP figures are based on IFRS, adjusted for acquisition-related charges, share-based payment costs, restructuring charges, Linaro-related charges and profit on disposal and impairment of available-for-sale investments. For reconciliation of IFRS measures to normalised non-IFRS measures detailed in this document, see notes 5.1 to 5.16.

**

Net cash generation is defined as movement on cash, cash equivalents, short-term investments and marketable securities, adding back dividend payments, investment and acquisition consideration, restructuring payments, other acquisition-related payments, Linaro-related charges, and share-based payroll taxes, and deducting inflows from share option exercises and proceeds from investment disposals - see notes 5.8 to 5.12.

***

Dollar revenues are based on the group's actual dollar invoicing, where applicable, and using the rate of exchange applicable on the date of the transaction for invoicing in currencies other than dollars. Approximately 95% of invoicing is in dollars.

 

CONTACTS:

 

Sarah West/Daniel Thöle Tim Score/Ian Thornton

Brunswick ARM Holdings plc

+44 (0)207 404 5959 +44 (0)1223 400400

 

Financial review

(IFRS unless otherwise stated)

 

Total revenues

Total dollar revenues in Q3 2010 were $158.1 million, up 29% versus Q3 2009. Q3 sterling revenues of £100.4 million were up 34% year-on-year. 

 

Year-to-date dollar revenues amounted to $451.7 million, up 29% on 2009.

 

License revenues

Total dollar license revenues in Q3 2010 increased by 33% year-on-year to $52.7m, representing 33% of group revenues. License revenues comprised $42.2 million from PD and $10.5 million from PIPD. 

 

Royalty revenues

Total dollar royalty revenues in Q3 2010 increased year-on-year by 31% to $81.7 million, representing 52% of group revenues. Royalty revenues comprised $70.4 million from PD and $11.3 million from PIPD. 

 

Royalties are recognised one quarter in arrears with royalties in Q3 generated from semiconductor unit shipments in Q2. PD royalty revenues in Q3 2010 increased 33% year-on-year. This compares with industry revenues1 increasing by about 25% in the shipment period (i.e. Q2 2010 compared to Q2 2009), demonstrating ARM's continuing market share gains over the last 12 months.

 

Total PIPD royalties of $11.3 million included $0.6 million of catch-up royalties. Underlying royalty revenues increased by 16% year-on-year.

 

Development Systems and Service revenues

Sales of development systems in Q3 2010 were $15.6 million, an increase of 11% year-on-year and representing 10% of group revenues. Three large software tools deals were signed during the quarter and, given that deals of this type are infrequent, development system revenues in Q4 2010 are expected to be closer to Q2 2010 revenues of $13.4m.

 

Service revenues in Q3 2010 were $8.1 million, an increase of 15% year-on-year and representing 5% of group revenues.

 

Gross margins

Gross margins in Q3 2010, excluding the share-based payments charge of £0.9 million (see below), were 94.2% compared to 94.9% in Q2 2010 and 92.9% in Q3 2009.

 

Operating expenses and operating margin

Normalised operating expenses (excluding acquisition-related, share-based payment, Linaro™-related and restructuring charges) were £56.6 million in Q3 2010 compared to £52.1 million in Q2 2010 and £46.0 million in Q3 2009. The sequential increase is largely due to the impact of a weaker dollar on the accounting of derivative instruments which has resulted in a net charge being included in general and administrative expenses in Q3 compared to a net credit in Q2. Normalised operating expenses in Q4 2010 (assuming effective exchange rates similar to current levels) are expected to be in the range £56-58 million.

 

Normalised research and development expenses were £26.4 million in Q3 2010, representing 26% of revenues, compared to £26.4 million in Q2 2010 and £21.5 million in Q3 2009. Normalised sales and marketing costs in Q3 2010 were £13.3 million, being 13% of revenues, compared to £12.8 million in Q2 2010 and £11.9 million in Q3 2009. Normalised general and administrative expenses in Q3 2010 were £16.9 million, representing 17% of revenues, compared to £12.9 million in Q2 2010 and £12.6 million in Q3 2009.

 

Normalised operating margin in Q3 2010 was 37.7% compared to 42.7% in Q2 2010 and 31.7% in Q3 2009.

 

Total operating expenses in Q3 2010 were £74.9 million (Q3 2009: £62.2 million) including amortisation of intangible assets and other acquisition-related charges of £2.9 million (Q3 2009: £3.8 million), £12.2 million (Q3 2009: £5.8 million) in relation to share-based payments and related payroll taxes and Linaro-related charges of £3.2 million (Q3 2009: £nil). Total share-based payments and related payroll tax charges of £13.1 million in Q3 2010 were included within cost of revenues (£0.9 million), research and development (£7.9 million), sales and marketing (£2.5 million) and general and administrative (£1.8 million). Normalised income statements for Q3 2010 and Q3 2009 are included in notes 5.13 and 5.14 below which reconcile IFRS to the normalised non-IFRS measures referred to in this earnings release.

 

As reported in Q2, ARM announced, along with several partners, the formation of Linaro, a not-for-profit company, set up to develop optimised Linux software and tools for ARM processor-based chips. At the end of last quarter Linaro was a 100% controlled subsidiary of ARM, but as other members have now taken up board seats, Linaro ceased to be controlled as a subsidiary at the end of Q3. Linaro-related charges in Q3 2010 of £3.2 million were charged to the profit and loss account. No further Linaro-related charges are expected to be incurred in the 12 months post launch (June 2010).

 

Earnings and taxation

Profit before tax in Q3 2010 was £19.6 million compared to £7.7 million in Q3 2009. After adjusting for acquisition-related, share-based payments, Linaro-related and restructuring charges, normalised profit before tax in Q3 2010 was £38.8 million compared to £24.3 million in Q3 2009. The Group's effective normalised tax rate in Q3 2010 was 27.5% (IFRS: 24.5%) giving a year-to-date normalised tax rate of 27.4% (IFRS: 25.1%). The tax rate under IFRS is lower than the normalised tax rate due primarily to the impact of tax credits arising on share-based payments.

 

In Q3 2010, fully diluted earnings per share prepared under IFRS were 1.09 pence (5.16 cents per ADS2) compared to earnings per share of 0.53 pence (2.54 cents per ADS) in Q3 2009. Normalised fully diluted earnings per share in Q3 2010 were 2.08 pence per share (9.82 cents per ADS) compared to 1.34 pence (6.44 cents per ADS) in Q3 2009. 

 

Balance sheet

Intangible assets at 30 September 2010 were £543.9 million, comprising goodwill of £529.0 million and other intangible assets of £14.9 million, compared to £556.0 million and £18.1 million respectively at 30 June 2010.

 

Total accounts receivable were £70.7 million at 30 September 2010, comprising £56.8 million of trade receivables and £13.9 million of amounts recoverable on contracts, compared to £91.8 million at 30 June 2010, comprising £80.0 million of trade receivables and £11.8 million of amounts recoverable on contracts. Days sales outstanding (DSOs) were 41 at 30 September 2010 compared to 34 at 30 June 2010 and 43 at 30 September 2009.

 

Cash flow

Net cash at 30 September 2010 was £251.9 million compared to £202.3 million at 30 June 2010. Normalised free cash flow in Q3 2010 was £65.0 million.

 

Operating review

 

Backlog

Group order backlog at the end of Q3 2010 is up more than 10% sequentially. This is ARM's highest ever backlog, driven partly by long-term strategic deals, including TSMC licensing ARM's advanced physical IP and a major semiconductor company acquiring an architecture license. 

 

Based on the revenue recognition profile of these deals and the mix of potential deals in the opportunity pipeline, prospects for backlog in the last quarter of 2010 remain promising.

 

Processor licensing

A total of twenty-two processor licenses were signed in Q3. 

 

The majority of these licenses were for non-mobile applications. Eight licenses where signed for enterprise applications with Cortex™-A series processors taking ARM technology into new markets such as high-end networking infrastructure products and servers. Ten licenses were signed for consumer electronics and embedded applications such as digital TVs, microcontrollers and sensors. Four licenses were signed for ARM processors in mobile applications such as chips for baseband modems and for the main applications processors in smartphones and mobile computers.

 

Eighteen of the licenses were for ARM's advanced Cortex and Mali™ graphics, including five Cortex-A9 processor licenses for use across all of ARM's target markets. In addition, a major semiconductor company became an architecture licensee with a focus on server applications.

 

Q3 2010 and Cumulative Processor Licensing Analysis

 

Existing

Licensees

New Licensees

Quarter Total

Cumulative Total

ARM7™

1

1

174

ARM9™

1

1

267

ARM11™

1

1

79

Cortex-A

4

1

5

48

Cortex-R

1

1

19

Cortex-M

6

4

10

76

Mali

1

1

2

31

Other

1

1

22

Total

14

8

22

716

 

Processor royalties

Royalties are recognised one quarter in arrears with royalties in Q3 generated from semiconductor unit shipments in Q2. PD dollar royalty revenues in Q3 2010 increased 33% year-on-year. This compares with industry revenues increasing by about 25% in the shipment period (i.e. Q2 2010 compared to Q2 2009), demonstrating ARM's market share gains over the last 12 months.

 

Q3 processor royalty revenue came from the sales of 1.5 billion ARM technology-based chips. The Cortex family now represents 9% of units shipped up from 2% in the same quarter one year ago. This increase is primarily due to Cortex-M series shipments in microcontrollers and wireless networking chips, and Cortex-A series shipments driven by high-end smartphones adopting smarter applications processors.

 

This continuing growth of Cortex-A series shipments has resulted in the average royalty per chip increasing to 4.7c this quarter from 4.5c in the previous quarter.

 

Q3 2010 Processor Unit Shipment Analysis

Processor Family

Unit Shipments

 

Market Segment

Unit Shipments

ARM7

49%

 

Mobile

61%

ARM9

33%

 

Enterprise

16%

ARM11

9%

 

Home

5%

Cortex

9%

 

Embedded

18%

 

ARM continued to gain share in non-mobile end-markets. Shipments of ARM processor-based microcontrollers grew over 65% year-on-year, compared to about 50% for the overall microcontroller market. The majority of this growth was due to a tenfold increase in the sale of Cortex-M based chips for microcontrollers.

 

The rapid growth of smartphones and the introduction of mobile computers, such as tablets, continue to benefit ARM. In Q3 2010 ARM's customers reported about a 35% year-on-year increase in shipments of mobile handset chips, driven by a 50% growth in smartphone shipments. For the quarter, ARM achieved an average of 2.7 ARM technology-based chips per mobile handset3, up from 2.6 in the prior quarter, and up from 2.1 a year ago. ARM's momentum in mobile computing continued with leading OEMs, such as Dell, RIM and Samsung, announcing mobile computers utilizing ARM technology-based chips, and with Beijing Nufront announcing a high-performance chip for Linux-based laptops for China, with a 2GHz dual-core Cortex-A9 processor and Mali graphics processor.

PIPD licensing

ARM signed three physical IP licenses in Q3 for new royalty-bearing platforms, at the 20, 28, and 65 nm nodes. Each platform contains a wide range of physical IP technology components including standard cell libraries and memories. Cumulatively, 76 physical IP licenses have now been signed and it is this base of platform licenses that is driving ARM's future royalty potential. 

 

As already reported, at the beginning of the quarter TSMC licensed two platforms at the advanced 28 and 20 nm nodes. Our early access to TSMC's process technology puts ARM in a good position to generate royalties as semiconductor companies start fabrication on these advanced nodes. In addition, a leading foundry licensed another physical IP platform to create a high-density variant of one of their process nodes. 

 

ARM is seeing increasing demand for physical IP optimised for use with our advanced Cortex-A series processors. These packages enable the licensee to reproduce a high-performance, low-power processor implementation using pre-built components. During the quarter we signed three licenses for Cortex-A9 processor optimisation packages at 32 and 40nm nodes, for use in digital TV, networking infrastructure and server applications.

 

Q3 2010 and Cumulative PIPD Licensing Analysis

 

 

Process Node

Total

 

Platform analysis

Royalty Bearing Platforms

 

 (nm)

 

 

(nm)

at Each Node

New Platform Licenses

22/20

1

 

22/20

1

 

32/28

1

 

32/28

7

 

65

1

 

45/40

8

 

 

 

 

65

12

 

 

 

 

90

11

 

 

 

 

130

17

 

 

 

 

180 to 250

20

 

 

 

 

Total

76

PIPD royalties

Physical IP royalties are generated mainly from chips manufactured in foundries such as TSMC, UMC and GLOBALFOUNDRIES. Royalties are recognised one quarter in arrears with royalties in Q3 generated from semiconductor unit shipments in Q2. 

 

Underlying PIPD royalties in Q3 2010 were $10.7 million, up 11% sequentially and 16% higher than the $9.2 million reported in Q3 2009. More than 30 companies are now building chips using ARM's advanced processors at 65nm and below, together driving royalties from 10 platform licenses. In Q3, these nodes generated about 30% of PIPD's royalties, up from about 15% a year ago.

 

People

At 30 September 2010, ARM had 1,861 full-time employees, a net increase of 151 since the start of the year, mainly engineers into ARM's processor R&D team. At the end of Q3, the group had 773 employees based in the UK, 496 in the US, 219 in Continental Europe, 272 in India and 101 in the Asia Pacific region. 

 

Given the broad range of opportunities, ARM is investing in its R&D programs and operations, and expects some further recruitment in Q4 2010.

 

Principal risks and uncertainties

The principal risks and uncertainties faced by the Group that could affect the results for the first nine months of 2010 and beyond are noted within the Annual Report on Form 20-F for the fiscal year ended 31 December 2009. There have been no changes to these risks that would materially impact the Group in the foreseeable future. These include but are not limited to: ARM's quarterly results may fluctuate significantly and be unpredictable which could adversely affect the market price of ARM ordinary shares; general economic conditions may reduce ARM's revenues and harm its business; and ARM competes in the intensely competitive semiconductor market.

 

ARM Holdings plc

Consolidated balance sheet - IFRS

 

 

30 September

31 December

 

2010

2009

 

Unaudited

Audited

 

£'000

£'000

Assets

Current assets:

Financial assets: Cash and cash equivalents

38,229

34,489

Short-term investments

213,627

105,524

Short-term marketable securities

-

1,795

Embedded derivatives

1,310

2,480

Fair value of currency exchange contracts

1,492

457

Accounts receivable (see note 3)

70,729

65,247

Prepaid expenses

15,650

14,221

Other debtors (note 4)

24,311

9,414

Current tax assets

1,394

350

Inventories: finished goods

1,665

1,680

Total current assets

368,407

235,657

Non-current assets:

Financial assets: Available-for-sale investments

18,055

9,432

Prepaid expenses and other assets

2,250

1,611

Property, plant and equipment

14,354

13,565

Goodwill

529,042

516,798

Other intangible assets

14,905

24,696

Deferred tax assets

65,788

42,724

Total non-current assets

644,394

608,826

Total assets

1,012,801

844,483

Liabilities and shareholders' equity

Current liabilities:

Financial liabilities: Accounts payable

4,955

2,280

Accrued and other liabilities

60,804

46,688

Current tax liabilities

12,323

16,536

Deferred revenue

71,249

39,562

Total current liabilities

149,331

105,066

Non-current liabilities:

Deferred tax liabilities

270

720

Total liabilities

149,601

105,786

Net assets

863,200

738,697

Capital and reserves attributable to equity holders of the Company

Share capital

672

672

Share premium account

351,578

351,578

Share option reserve

61,474

61,474

Retained earnings

353,460

241,950

Revaluation reserve

-

(155)

Cumulative translation adjustment

96,016

83,178

Total equity

863,200

738,697

 

ARM Holdings plc

Consolidated income statement - IFRS

 

 

Quarter ended

Quarter ended

Nine months ended

Nine months ended

 

30 September 2010

30 September 2009

30 September 2010

30 September 2009

 

Unaudited

Unaudited

Unaudited

Unaudited

 

£'000

£'000

£'000

£'000

 

 

 

Revenues

100,353

75,160

292,649

219,840

Cost of revenues

(6,752)

(5,775)

(19,505)

(20,058)

Gross profit

93,601

69,385

273,144

199,782

Research and development

(38,290)

(27,094)

(103,115)

(81,833)

Sales and marketing

(17,846)

(15,030)

(50,401)

(45,466)

General and administrative

(18,789)

(20,026)

(46,915)

(46,440)

Total operating expenses, net

(74,925)

(62,150)

(200,431)

(173,739)

Profit from operations

18,676

7,235

72,713

26,043

Investment income

910

467

2,394

1,207

Interest payable

-

(37)

-

(113)

Profit before tax

19,586

7,665

75,107

27,137

Tax

(4,789)

(774)

(18,842)

(4,039)

Profit for the period

14,797

6,891

56,265

23,098

Earnings per share

Basic and diluted earnings

14,797

6,891

56,265

23,098

Number of shares ('000)

Basic weighted average number of shares

1,318,120

1,268,613

1,310,341

1,262,735

Effect of dilutive securities: Share options and awards

36,402

32,489

37,936

29,399

Diluted weighted average number of shares

1,354,522

1,301,102

1,348,277

1,292,134

Basic EPS (pence)

1.1

0.5

4.3

1.8

Diluted EPS (pence)

1.1

0.5

4.2

1.8

Diluted earnings per ADS (cents)

5.2

2.5

19.7

8.6

All activities relate to continuing operations. 

All of the profit for the period is attributable to the equity shareholders of the parent.

 

ARM Holdings plc

Consolidated statement of comprehensive income - IFRS

 

 

 

Quarter ended

Quarter ended

Nine months ended

Nine months ended

 

30 September 2010

30 September 2009

30 September 2010

30 September 2009

 

Unaudited

Unaudited

Unaudited

Unaudited

 

£'000

£'000

£'000

£'000

 

Profit for the period

14,797

6,891

56,265

23,098

Other comprehensive income:

Unrealised holding gain on available-for-sale

investments (net of tax of £nil)

 

-

 

(15)

 

155

 

126

Currency translation adjustment

(29,268)

17,219

12,838

(55,565)

Other comprehensive income /(loss) for the period

(29,268)

17,204

12,993

(55,439)

Total comprehensive income/(loss) for the period

(14,471)

24,095

69,258

(32,341)

 

ARM Holdings plc

Consolidated statement of changes in shareholders' equity - IFRS

 

 

Share

Share

Reval-

Cumulative

Share

premium

option

Retained

-uation

translation

capital

account

reserve

earnings

reserve

adjustment

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 1 January 2009 (audited)

672

351,578

61,474

182,008

(285)

144,896

740,343

Profit for the period

23,098

23,098

Other comprehensive income:

Unrealised holding gain on available-for-sale investment

126

126

Currency translation adjustment

(55,565)

(55,565)

Total comprehensive income/(expense) for the nine month period

23,098

126

(55,565)

(32,341)

Dividends

(16,634)

(16,634)

Credit in respect of employee share schemes

13,294

13,294

Movement on tax arising on share options and awards

5,577

5,577

Proceeds from sale of own shares

10,606

10,606

12,843

12,843

At 30 September 2009 (unaudited)

672

351,578

61,474

217,949

(159)

89,331

720,845

 

 

At 1 January 2010 (audited)

672

351,578

61,474

241,950

(155)

83,178

738,697

Profit for the period

56,265

56,265

Other comprehensive income:

Unrealised holding gain on available-for-sale investments

155

155

Currency translation adjustment

12,838

12,838

Total comprehensive income for nine month period

56,265

155

12,838

69,258

Dividends

(19,022)

(19,022)

Credit in respect of employee share schemes

19,943

19,943

Movement on tax arising on share options and awards

31,189

31,189

Proceeds from sale of own shares

23,135

23,135

55,245

55,245

At 30 September 2010 (unaudited)

672

351,578

61,474

353,460

96,016

863,200

 

 

Notes to the Financial Information

 

(1) Basis of preparation

The financial information prepared in accordance with the Group's IFRS accounting policies comprises the consolidated balance sheets as of 30 September 2010 and 31 December 2009, consolidated income statements and consolidated statements of comprehensive income for the three months and nine months ended 30 September 2010 and 2009, and consolidated statements of changes in shareholders' equity for the nine months ended 30 September 2010 and 2009, together with related notes. This condensed set of consolidated interim financial information for the nine months ended 30 September 2010 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority. This financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2009, which have been prepared in accordance with IFRSs as adopted by the European Union.

 

 

(2) Share-based payment costs and acquisition-related expenses

Included within the consolidated income statement for the quarter ended 30 September 2010 are total share-based payment costs (including related payroll taxes) of £13.1 million (2009: £6.3 million), allocated £0.9 million (2009: £0.4 million) in cost of revenues, £7.9 million (2009: £3.8 million) in research and development expenses, £2.5 million (2009: £1.2 million) in sales and marketing expenses and £1.8 million (2009: £0.9 million) in general and administrative expenses.

 

Included within the consolidated income statement for the nine months ended 30 September 2010 are total share-based payment costs (including related payroll taxes) of £31.3 million (2009: £16.7 million), allocated £2.1 million (2009: £1.2 million) in cost of revenues, £18.8 million (2009: £10.0 million) in research and development expenses, £6.0 million (2009: £3.2 million) in sales and marketing expenses and £4.4 million (2009: £2.3 million) in general and administrative expenses.

 

Also included within operating expenses for the quarter ended 30 September 2010 is amortisation of intangibles acquired on business combinations of £2.7 million (2009: £3.6 million), allocated £0.9 million (2009: £1.8 million) in research and development expenses and £1.8 million (2009: £1.8 million) in sales and marketing expenses.

 

 

(3) Accounts receivable

Included within accounts receivable at 30 September 2010 are £13.9 million (31 December 2009: £12.4 million) of amounts recoverable on contracts.

 

 

(4) Other debtors

Included within other debtors at 30 September 2010 is £15.3 million (31 December 2009: £nil) of amounts paid with respect to the interim dividend for the year to 31 December 2010, which has been declared as being due to the shareholders on 4 October 2010. In accordance with IAS 10 'Events after the reporting period', dividends are not recognised until they have been paid to the shareholders.

 

(5) Non-GAAP measures

The following non-GAAP measures, including reconciliations to the IFRS measures, have been used in this earnings release. These measures have been presented as they allow a clearer comparison of operating results that exclude acquisition-related charges, share-based payment costs, restructuring charges, profit on disposal and impairment of available-for-sale investments, and Linaro-related charges. Full reconciliations of Q3 2010, Q3 2009, 9M 2010 and 9M 2009, are shown in notes 5.13 to 5.16. All figures in £'000 unless otherwise stated.

 

Summary normalised figures

Q3 2010

Q3 2009

Q2 2010

9M 2010

9M 2009

Revenues (£'000)

100,353

75,160

99,950

292,649

219,840

Revenues ($'000)

158,120

123,007

150,299

451,715

349,435

Gross margin

94.2%

92.9%

94.9%

94.0%

91.4%

Operating expenses

56,642

45,986

52,128

157,759

137,589

Profit from operations

37,872

23,833

42,678

117,456

63,369

Operating margin

37.7%

31.7%

42.7%

40.1%

28.8%

Profit before tax

38,782

24,263

43,460

119,850

64,463

Earnings per share (diluted)

2.08p

1.34p

2.34p

6.45p

3.66p

Cash

251,856

121,689

202,257

251,856

121,689

Cash generation

64,991

28,338

30,414

139,248

55,420

 

 

 

 

(5.1)

(5.2)

(5.3)

(5.4)

(5.5)

Q3 2010

Q3 2009

Q2 2010

9M 2010

9M 2009

Revenues (£'000)

100,353

75,160

99,950

292,649

219,840

ARM's effective exchange rate ($/£)

1.58

1.64

1.50

1.54

1.59

Revenues ($'000)

158,120

123,007

150,299

451,715

349,435

 

 

 

(5.6)

(5.7)

30 September

2010

31

December

2009

Cash and cash equivalents

38,229

34,489

Short-term investments

213,627

105,524

Short-term marketable securities

-

1,795

Normalised cash

251,856

141,808

 

 

 

 

(5.8)

(5.9)

(5.10)

(5.11)

(5.12)

Q3 2010

Q3 2009

Q2 2010

9M 2010

9M 2009

Normalised cash at end of period (as above)

251,856

121,689

202,257

251,856

121,689

Less: Normalised cash at beginning of period

(202,257)

(88,217)

(195,950)

(141,808)

(78,789)

Add back: Cash outflow from investments and acquisitions (net of cash acquired)

 

3,746

 

1,346

 

3,872

 

8,618

 

4,400

Add back: Cash outflow from payment of dividends

15,304

-

19,022

34,326

16,634

Add back: Cash outflow from restructuring payments

370

-

2,253

4,510

1,434

Add back: Cash outflow from share-based payroll taxes

91

118

419

3,022

658

Add back: Cash outflow from payments related to Linaro

621

-

1,238

1,859

-

Less: Cash inflow from exercise of share options

(4,740)

(6,598)

(2,697)

(23,135)

(10,606)

Normalised cash generation

64,991

28,338

30,414

139,248

55,420

 

 

 (5.13) Normalised income statement for Q3 2010

 

 

 

 

 

Normalised

 

 

Share-based payments

 

Normalised incl share-based payments

 

 

Intangible amortisa-tion

 

Other acquisition -related charges

 

 

Linaro -related charges

 

 

 

 

IFRS

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Revenues

100,353

-

100,353

-

-

-

100,353

Cost of revenues

(5,839)

(913)

(6,752)

-

-

-

(6,752)

Gross profit

94,514

(913)

93,601

-

-

-

93,601

Research and development

(26,392)

(7,858)

(34,250)

(871)

-

(3,169)

(38,290)

Sales and marketing

(13,337)

(2,490)

(15,827)

(1,870)

(114)

(35)

(17,846)

General and administrative

(16,913)

(1,833)

(18,746)

-

-

(43)

(18,789)

Total operating expenses

(56,642)

(12,181)

(68,823)

(2,741)

(114)

(3,247)

(74,925)

Profit from operations

37,872

(13,094)

24,778

(2,741)

(114)

(3,247)

18,676

Investment income

910

-

910

-

-

-

910

Profit before tax

38,782

(13,094)

25,688

(2,741)

(114)

(3,247)

19,586

Tax

(10,657)

3,917

(6,740)

1,010

32

909

(4,789)

Profit for the period

28,125

(9,177)

18,948

(1,731)

(82)

(2,338)

14,797

Earnings per share (assuming dilution)

Shares outstanding ('000)

1,354,522

1,354,522

1,354,522

Earnings per share - pence

2.08

1.40

1.09

ADSs outstanding ('000)

451,507

451,507

451,507

Earnings per ADS - cents

9.82

6.61

5.16

 

(5.14) Normalised income statement for Q3 2009

 

 

 

 

 

Normalised

 

 

Share-based payments

Normalised incl share-based compen-sation

 

 

Intangible amortisa-tion

 

Other acquisition -related charges

 

 

Restruct-

-uring charges

 

 

 

 

IFRS

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Revenues

75,160

-

75,160

-

-

-

75,160

Cost of revenues

(5,341)

(434)

(5,775)

-

-

-

(5,775)

Gross profit

69,819

(434)

69,385

-

-

-

69,385

Research and development

(21,542)

(3,772)

(25,314)

(1,780)

-

-

(27,094)

Sales and marketing

(11,859)

(1,196)

(13,055)

(1,861)

(114)

-

(15,030)

General and administrative

(12,585)

(881)

(13,466)

(3)

-

(6,557)

(20,026)

Total operating expenses

(45,986)

(5,849)

(51,835)

(3,644)

(114)

(6,557)

(62,150)

Profit from operations

23,833

(6,283)

17,550

(3,644)

(114)

(6,557)

7,235

Investment income

467

-

467

-

-

-

467

Interest payable

(37)

-

(37)

-

-

-

(37)

Profit before tax

24,263

(6,283)

17,980

(3,644)

(114)

(6,557)

7,665

Tax

(6,807)

2,800

(4,007)

1,364

32

1,837

(774)

Profit for the period

17,456

(3,483)

13,973

(2,280)

(82)

(4,720)

6,891

Earnings per share (assuming dilution)

Shares outstanding ('000)

1,301,102

1,301,102

1,301,102

Earnings per share - pence

1.34

1.07

0.53

ADSs outstanding ('000)

433,701

433,701

433,701

Earnings per ADS - cents

6.44

5.15

2.54

 

(5.15) Normalised income statement for 9M 2010

 

 

 

 

 

Normalised

 

 

Share-based payments

 

Normalised incl share-based payments

 

 

Intangible amortisa-tion

 

Other acquisition -related charges

 

 

Linaro -related charges

 

 

 

 

IFRS

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Revenues

292,649

-

292,649

-

-

-

292,649

Cost of revenues

(17,434)

(2,071)

(19,505)

-

-

-

(19,505)

Gross profit

275,215

(2,071)

273,144

-

-

-

273,144

Research and development

(77,950)

(18,851)

(96,801)

(2,873)

-

(3,441)

(103,115)

Sales and marketing

(38,188)

(5,991)

(44,179)

(5,729)

(342)

(151)

(50,401)

General and administrative

(41,621)

(4,401)

(46,022)

-

-

(893)

(46,915)

Total operating expenses

(157,759)

(29,243)

(187,002)

(8,602)

(342)

(4,485)

(200,431)

Profit from operations

117,456

(31,314)

86,142

(8,602)

(342)

(4,485)

72,713

Investment income

2,394

-

2,394

-

-

-

2,394

Profit before tax

119,850

(31,314)

88,536

(8,602)

(342)

(4,485)

75,107

Tax

(32,870)

9,501

(23,369)

3,175

96

1,256

(18,842)

Profit for the period

86,980

(21,813)

65,167

(5,427)

(246)

(3,229)

56,265

Earnings per share (assuming dilution)

Shares outstanding ('000)

1,348,277

1,348,277

1,348,277

Earnings per share - pence

6.45

4.83

4.17

ADSs outstanding ('000)

449,426

449,426

449,426

Earnings per ADS - cents

30.50

22.85

19.73

 

(5.16) Normalised income statement for 9M 2009

 

 

 

 

 

Normalised

 

 

Share-based payments

Normalised incl share-based compen-sation

 

 

Intangible amortisa-tion

 

Other acquisition -related charges

 

Disposal / impairment of investments

 

 

Restruct-

-uring charges

 

 

 

 

IFRS

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Revenues

219,840

-

219,840

-

-

-

-

219,840

Cost of revenues

(18,882)

(1,176)

(20,058)

-

-

-

-

(20,058)

Gross profit

200,958

(1,176)

199,782

-

-

-

-

199,782

Research and development

(65,875)

(10,036)

(75,911)

(5,922)

-

-

-

(81,833)

Sales and marketing

(35,810)

(3,183)

(38,993)

(6,131)

(342)

-

-

(45,466)

General and administrative

(35,904)

(2,342)

(38,246)

(15)

-

(188)

(7,991)

(46,440)

Total operating expenses

(137,589)

(15,561)

(153,150)

(12,068)

(342)

(188)

(7,991)

(173,739)

Profit from operations

63,369

(16,737)

46,632

(12,068)

(342)

(188)

(7,991)

26,043

Investment income

1,207

-

1,207

-

-

-

-

1,207

Interest payable

(113)

-

(113)

-

-

-

-

(113)

Profit before tax

64,463

(16,737)

47,726

(12,068)

(342)

(188)

(7,991)

27,137

Tax

(17,156)

6,205

(10,951)

4,521

96

53

2,242

(4,039)

Profit for the period

47,307

(10,532)

36,775

(7,547)

(246)

(135)

(5,749)

23,098

Earnings per share (assuming dilution)

Shares outstanding ('000)

1,292,134

1,292,134

1,292,134

Earnings per share - pence

3.66

2.85

1.79

ADSs outstanding ('000)

430,711

430,711

430,711

Earnings per ADS - cents

17.57

13.66

8.58

 

Notes

 

The results shown for Q3 2010, Q2 2010, Q3 2009, 9M 2010, and 9M 2009 are unaudited. The results shown for FY 2009 are audited. The consolidated financial information contained in this announcement does not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts of the Company in respect of the financial year ended 31 December 2009 were approved by the Board of directors on 31 March 2010 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified and did not contain an emphasis of matter paragraph nor any statement under Section 498 of the Companies Act 2006.

 

The results for ARM for Q3 2010 and previous quarters as shown reflect the accounting policies as stated in Note 1 to the financial statements in the Annual Report and Accounts filed with Companies House in the UK for the fiscal year ended 31 December 2009 and in the Annual Report on Form 20-F for the fiscal year ended 31 December 2009.

 

This document contains forward-looking statements as defined in section 102 of the Private Securities Litigation Reform Act of 1995. These statements are subject to risk factors associated with the semiconductor and intellectual property businesses. When used in this document, the words "anticipates", "may", "can", "believes", "expects", "projects", "intends", "likely", similar expressions and any other statements that are not historical facts, in each case as they relate to ARM, its management or its businesses and financial performance and condition are intended to identify those assertions as forward-looking statements. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables, many of which are beyond our control. These variables could cause actual results or trends to differ materially and include, but are not limited to: failure to realize the benefits of acquisitions, unforeseen liabilities arising from acquisitions, price fluctuations, actual demand, the availability of software and operating systems compatible with our intellectual property, the continued demand for products including ARM's intellectual property, delays in the design process or delays in a customer's project that uses ARM's technology, the success of our semiconductor partners, loss of market and industry competition, exchange and currency fluctuations, any future strategic investments or acquisitions, rapid technological change, regulatory developments, ARM's ability to negotiate, structure, monitor and enforce agreements for the determination and payment of royalties, actual or potential litigation, changes in tax laws, interest rates and access to capital markets, political, economic and financial market conditions in various countries and regions and capital expenditure requirements.

 

More information about potential factors that could affect ARM's business and financial results is included in ARM's Annual Report on Form 20-F for the fiscal year ended 31 December 2009 including (without limitation) under the captions, "Risk Factors"(on pages 4 to 11) which is on file with the Securities and Exchange Commission (the "SEC") and available at the SEC's website at www.sec.gov.

 

About ARM

 

ARM designs the technology that lies at the heart of advanced digital products, from wireless, networking and consumer entertainment solutions to imaging, automotive, security and storage devices. ARM's comprehensive product offering includes 32-bit RISC microprocessors, graphics processors, video engines, enabling software, cell libraries, embedded memories, high-speed connectivity products, peripherals and development tools. Combined with comprehensive design services, training, support and maintenance, and the company's broad Partner community, they provide a total system solution that offers a fast, reliable path to market for leading electronics companies. More information on ARM is available at http://www.arm.com.

 

ARM is a registered trademark of ARM Limited. ARM7, ARM9, ARM11, Cortex and Mali are trademarks of ARM Limited. All other brands or product names are the property of their respective holders. "ARM" is used to represent ARM Holdings plc; its operating company ARM Limited; and the regional subsidiaries: ARM Inc.; ARM KK; ARM Korea Ltd.; ARM Taiwan Limited; ARM France SAS; ARM Consulting (Shanghai) Co. Ltd.; ARM Belgium Services BVBA; ARM Germany GmbH; ARM Embedded Technologies Pvt. Ltd.; ARM Norway AS; and ARM Sweden AB.

 

 

 

 


1 Source: Semiconductor Industry Association, July 2010

2 Each American Depositary Share (ADS) represents three shares.

3 The number of chips per handset does not include mobile computers, for example tablets and netbooks

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTUVSBRRRARUAA

Related Shares:

ARM.L
FTSE 100 Latest
Value8,275.66
Change0.00